{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:16Z","timestamp":1788871756018,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000396","name":"Technology Strategy Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/jid.2011.389","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T04:49:05Z","timestamp":1323319745000},"page":"820-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"P2","title":["Novel Molecular Therapies for Heritable Skin Disorders"],"prefix":"10.1016","volume":"132","author":[{"given":"Jouni","family":"Uitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Christiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Irwin","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.389_bb0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature08792","article-title":"Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients","volume":"464","author":"Agarwal","year":"2010","journal-title":"Nature"},{"key":"10.1038\/jid.2011.389_bb0015","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/jid.2011.169","article-title":"Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex","volume":"131","author":"Atkinson","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000123","article-title":"Molecular basis of inherited skin-blistering disorders and therapeutic implications","volume":"8","author":"Aumailley","year":"2006","journal-title":"Exp Rev Mol Med"},{"key":"10.1038\/jid.2011.389_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.10260","article-title":"Participation of bone marrow derived cells in cutaneous wound healing","volume":"196","author":"Badiavas","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1038\/jid.2011.389_bb0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archderm.139.4.510","article-title":"Treatment of chronic wounds with bone marrow-derived cells","volume":"139","author":"Badiavas","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2011.389_bb0035","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.1720261","article-title":"Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities","volume":"254","author":"Bonifas","year":"1991","journal-title":"Science"},{"key":"10.1038\/jid.2011.389_bb0040","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/jid.2010.75","article-title":"Animal models of epidermolysis bullosa: update 2010","volume":"130","author":"Bruckner-Tuderman","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1038\/jid.2011.389_bb0050","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/mt.2008.114","article-title":"Zinc-finger nucleases: the next generation emerges","volume":"16","author":"Cathomen","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2011.389_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1523-1747.ep12371763","article-title":"Type VII collagen gene expression by human skin fibroblasts and keratinocytes in culture: influence of donor age and cytokine responses","volume":"102","author":"Chen","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2008.070977","article-title":"Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance","volume":"173","author":"Chino","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2011.389_bb0065","first-page":"199","article-title":"Molecular diagnosis of inherited skin diseases: the paradigm of dystrophic epidermolysis bullosa","volume":"11","author":"Christiano","year":"1996","journal-title":"Adv Dermatol"},{"key":"10.1038\/jid.2011.389_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2009.10.011","article-title":"Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa","volume":"28","author":"Chung","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1038\/jid.2011.389_bb0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1038\/jid.2011.389_bb0080","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0092-8674(91)90051-Y","article-title":"Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analysis","volume":"66","author":"Coulombe","year":"1991","journal-title":"Cell"},{"key":"10.1038\/jid.2011.389_bb0085","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/jid.2009.108","article-title":"Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database","volume":"129","author":"Feramisco","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0090","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of epidermolysis bullosa","volume":"58","author":"Fine","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.389_bb0095","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2011.389_bb0100","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1073\/pnas.1000044107","article-title":"Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice","volume":"107","author":"Fujita","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.389_bb0105","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1152092","article-title":"Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin","volume":"318","author":"Hanna","year":"2007","journal-title":"Science"},{"key":"10.1038\/jid.2011.389_bb0110","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5701060","article-title":"Single-nucleotide-specific siRNA targeting in a dominant-negative skin model","volume":"128","author":"Hickerson","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","article-title":"Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases","volume":"27","author":"Hockemeyer","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/jid.2011.389_bb0120","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1073\/pnas.1103388108","article-title":"Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy","volume":"108","author":"Howden","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.389_bb0125","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1046\/j.1365-2133.1999.02810.x","article-title":"Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation","volume":"140","author":"Irvine","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.389_bb0130","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1073\/pnas.1100332108","article-title":"Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells","volume":"108","author":"Itoh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.389_bb0135","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1111\/j.0022-202X.2005.23652.x","article-title":"Animal models of epidermolysis bullosa\u2212targets for gene therapy","volume":"124","author":"Jiang","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81894-2","article-title":"Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion","volume":"88","author":"Jonkman","year":"1997","journal-title":"Cell"},{"key":"10.1038\/jid.2011.389_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1087-0024.2005.10208.x","article-title":"Challenges in developing therapies for rare diseases including pachyonychia congenita","volume":"10","author":"Kaspar","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2011.389_bb0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Therapy"},{"key":"10.1038\/jid.2011.389_bb0155","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1038\/jid.2011.389_bb0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.det.2010.02.004","article-title":"Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa","volume":"28","author":"Kiuru","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1038\/jid.2011.389_bb0165","first-page":"950","article-title":"Somatic reversion\/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers","volume":"50","author":"Klein","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1038\/jid.2011.389_bb0170","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1126\/science.313.5791.1235c","article-title":"Why academic drug discovery makes sense","volume":"313","author":"Kozikowski","year":"2006","journal-title":"Science"},{"key":"10.1038\/jid.2011.389_bb0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molmed.2010.11.003","article-title":"Revertant mosaicism in skin: natural gene therapy","volume":"17","author":"Lai-Cheong","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1038\/jid.2011.389_bb0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/356244a0","article-title":"A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering","volume":"356","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1038\/jid.2011.389_bb0185","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","article-title":"First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder","volume":"18","author":"Leachman","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2011.389_bb0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1087-0024.2005.10207.x","article-title":"Gene therapy for autosomal dominant disorders of keratin","volume":"10","author":"Lewin","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2011.389_bb0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2164-8-92","article-title":"Human sterile alpha motif domain 9, a novel gene identified as down-regulated aggressive fibromatosis, is absent in the mouse","volume":"8","author":"Li","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1038\/jid.2011.389_bb0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/jid.2010.388","article-title":"Zebrafish: a model system to study heritable skin diseases","volume":"131","author":"Li","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: zebrafish swim into view","volume":"8","author":"Lieschke","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1038\/jid.2011.389_bb0210","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/jid.2011.59","article-title":"The phenotypic and molecular genetic features of pachyonychia congenita","volume":"131","author":"McLean","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0215","first-page":"72","article-title":"Disorders of keratinisation: from rare to common genetic diseases of skin and other epithelial tissues","volume":"76","author":"McLean","year":"2007","journal-title":"Ulster Med J"},{"key":"10.1038\/jid.2011.389_bb0220","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/jid.2011.85","article-title":"HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa","volume":"131","author":"Nagy","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.det.2009.10.016","article-title":"Animal models of epidermolysis bullosa","volume":"28","author":"Natsuga","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1038\/jid.2011.389_bb0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","article-title":"Generation of germline-competent induced pluripotent stem cells","volume":"448","author":"Okita","year":"2007","journal-title":"Nature"},{"key":"10.1038\/jid.2011.389_bb0235","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent stem cells without viral vectors","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"key":"10.1038\/jid.2011.389_bb0240","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMra040319","article-title":"Intermediate filament proteins and their associated diseases","volume":"351","author":"Omary","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2011.389_bb0245","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1365-2133.2010.09981.x","article-title":"Stem cell therapies for recessive dystrophic epidermolysis bullosa","volume":"163","author":"Petrova","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.389_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mjd.2002.120601","article-title":"Progress in heritable skin diseases: molecular bases and clinical implications","volume":"47","author":"Pulkkinen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.389_bb0255","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1101\/gad.8.21.2563","article-title":"A functional \u201cknock-out\u201d for human keratin 14","volume":"8","author":"Rugg","year":"1994","journal-title":"Genes Dev"},{"key":"10.1038\/jid.2011.389_bb0260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.2007.08114.x","article-title":"Functional redundancy of extracellular matrix protein 1 in epidermal differentiation","volume":"157","author":"Sercu","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.389_bb0265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.jid.5701040","article-title":"Development of therapeutic siRNAs for pachyonychia congenita","volume":"128","author":"Smith","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0270","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1242\/dev.01904","article-title":"Zebrafish penner\/lethal giant larvae 2 functions in hemidesmosome formation, maintenance of cellular morphology and growth regulation in the developing basal epidermis","volume":"132","author":"Sonawane","year":"2005","journal-title":"Development"},{"key":"10.1038\/jid.2011.389_bb0275","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/1523-1747.ep12277377","article-title":"Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts","volume":"85","author":"Stanley","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0280","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2133.1998.02499.x","article-title":"Specialized keratin expression pattern in human ridged skin as an adaptation to high physical stress","volume":"139","author":"Swensson","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.389_bb0285","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1038\/jid.2011.389_bb0290","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFR-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.389_bb0295","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1038\/jid.2011.389_bb0300","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","article-title":"Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa","volume":"131","author":"Tolar","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0305","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/jid.2011.125","article-title":"Cell-based therapy for RDEB: how does it work?","volume":"131","author":"Uitto","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0310","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/jid.2011.2","article-title":"Regenerative medicine for skin diseases: iPS cells to the rescue","volume":"131","author":"Uitto","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0315","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/ajmg.a.34067","article-title":"Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment: summary of the 2010 PXE International Research Meeting","volume":"155","author":"Uitto","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1038\/jid.2011.389_bb0320","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI115938","article-title":"Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases","volume":"90","author":"Uitto","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2011.389_bb0325","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/jid.2010.90","article-title":"Progress in epidermolysis bullosa research: toward treatment and cure","volume":"130","author":"Uitto","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0330","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.2010.29","article-title":"The future is much closer collaboration between the pharmaceutical industry and academic medical centers","volume":"87","author":"Vallance","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 2","key":"10.1038\/jid.2011.389_bb0335","first-page":"S67","volume":"130","author":"Venugopal","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0340","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2004-03-0846","article-title":"Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family","volume":"104","author":"Wada","year":"2004","journal-title":"Blood"},{"key":"10.1038\/jid.2011.389_bb0345","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2011.389_bb0350","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1038\/jid.2011.389_bb0355","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/jid.2011.20","article-title":"A large mutational study in pachyonychia congenita","volume":"131","author":"Wilson","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0360","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.200102079","article-title":"Discovery of a novel murine keratin 6 (K6) isoform explains the absence of hair and nail defects in mice deficient for K6a and K6b","volume":"154","author":"Wojcik","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2011.389_bb0365","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1083\/jcb.150.4.921","article-title":"Introducing a null mutation in the mouse K6alpha and K6beta genes reveals their essential structural role in the oral mucosa","volume":"150","author":"Wong","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2011.389_bb0370","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0375","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1523-1747.2003.12571.x","article-title":"Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone","volume":"121","author":"Woodley","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0380","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.det.2010.01.015","article-title":"Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa","volume":"28","author":"Yan","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1038\/jid.2011.389_bb0385","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"10.1038\/jid.2011.389_bb0390","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1038\/jid.2011.389_bb0395","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1038\/jid.2011.389_bb0400","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/jid.2011.41","article-title":"Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita","volume":"131","author":"Zhao","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.389_bb0405","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/stem.201","article-title":"Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells","volume":"27","author":"Zhou","year":"2009","journal-title":"Stem Cells"},{"key":"10.1038\/jid.2011.389_bb0410","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.stem.2009.05.023","article-title":"Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells","volume":"5","author":"Zou","year":"2009","journal-title":"Cell Stem Cell"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15356670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15356670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:46:28Z","timestamp":1743947188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15356670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0022202X15356670"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.389","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718345169.793493601","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Molecular Therapies for Heritable Skin Disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}